{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for aminosalicylic root_notes_note in Note (approximate match)
Status:
US Approved Rx
(2015)
First approved in 2015
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01445899: Phase 2 Interventional Completed Choroidal Neovascularization
(2012)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:opolimogene capmilisbac [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04267640: Phase 2 Interventional Unknown status Peripheral Artery Disease
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:zorecimeran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04588428: Phase 2 Interventional Completed Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
(2021)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04469270: Phase 3 Interventional Completed Diabetic Neuropathy, Painful
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04251117: Phase 1/Phase 2 Interventional Active, not recruiting HCC
(2020)
Source URL:
Class:
NUCLEIC ACID